Priaxon AG

Curated by Signal

Developer of small molecule therapeutics for target-ligand interactions

Overview

Developer of small molecule therapeutics for target-ligand interactions. PriaXplore is its proprietary technology suite that applies computational approaches, combined with complex synthetic chemistry to address thus far intractable molecular interactions of relevance in human health and disease with small molecule-based therapies.

Key facts

Founded: 2008
Headquarters: Munich, Germany
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

eaze
Online platform offering consultation services with sleep psychologists
Health TechnologyBerlin, Germany
LipoCheck
AI-powered application to detect lipoedema
Health TechnologyBerlin, Germany
MyaLink
Provider of remote patient support and monitoring for patients with myasthenia gravis and other rare diseases
Health TechnologyBerlin, Germany

About Priaxon AG

What does Priaxon AG do?

Developer of small molecule therapeutics for target-ligand interactions.

Where is Priaxon AG headquartered?

Priaxon AG is headquartered in Munich, Germany.

When was Priaxon AG founded?

Priaxon AG was founded in 2008.

Which sector is Priaxon AG in?

Priaxon AG operates in Health Technology.

Who are Priaxon AG's competitors?

Companies similar to Priaxon AG include eaze, LipoCheck, and MyaLink.